The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer

Keiichiro Nakamura, Atsushi Hongo, Junichi Kodama, Yuji Hiramatsu

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) are Kunitz-type serine protease inhibitors that have a broad inhibitory spectrum against serine proteases. This is the first study to investigate the role of HAI-1 and HAI-2 in endometrial cancer. We investigated the biological functions of HAI-1 and HAI-2 using KLE and HEC-251 endometrial cancer cell lines, thus HAI-1 and HAI-2 were examined in uterine normal endometrium, endometrial hyperplasia and cancer specimens by immunohistochemistry. HAI-1 and HAI-2 showed potential inhibitory effects on cell proliferation, migration and cellular invasion by reduction of matriptase and hepsin expression. This in turn led to an increase in the levels of E-cadherin and Slug, and a reduction in the levels of Vimentin, SIP1, Snail and Twist, and hence ER and PR signal transduction in endometrial cancer cells. The levels of HAI-1 and HAI-2 expression were significantly decreased in endometrial cancer specimens relative to the corresponding normal endometrium specimens. Low HAI-1 and HAI-2 expression was a significant predictor for a poor prognosis compared with high HAI-1 and HAI-2 expression. These findings indicate that HAI-1 and HAI-2 could be considered as therapeutic targets and used as favorable prognosis markers for endometrial cancer.

Original languageEnglish
Pages (from-to)2613-2624
Number of pages12
JournalInternational Journal of Cancer
Volume128
Issue number11
DOIs
Publication statusPublished - Jun 1 2011

Fingerprint

Endometrial Neoplasms
Endometrium
Endometrial Hyperplasia
Serine Proteinase Inhibitors
Gastropoda
Serine Proteases
Vimentin
Cadherins
Cell Movement
HGF activator
Signal Transduction
Immunohistochemistry
Cell Proliferation
Cell Line

Keywords

  • endometrial cancer
  • favorable prognosis marker
  • HAI-1
  • HAI-2
  • tumor suppressor gene

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer. / Nakamura, Keiichiro; Hongo, Atsushi; Kodama, Junichi; Hiramatsu, Yuji.

In: International Journal of Cancer, Vol. 128, No. 11, 01.06.2011, p. 2613-2624.

Research output: Contribution to journalArticle

Nakamura, Keiichiro ; Hongo, Atsushi ; Kodama, Junichi ; Hiramatsu, Yuji. / The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer. In: International Journal of Cancer. 2011 ; Vol. 128, No. 11. pp. 2613-2624.
@article{50f4fa07eea24493bab518183f6d67cd,
title = "The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer",
abstract = "Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) are Kunitz-type serine protease inhibitors that have a broad inhibitory spectrum against serine proteases. This is the first study to investigate the role of HAI-1 and HAI-2 in endometrial cancer. We investigated the biological functions of HAI-1 and HAI-2 using KLE and HEC-251 endometrial cancer cell lines, thus HAI-1 and HAI-2 were examined in uterine normal endometrium, endometrial hyperplasia and cancer specimens by immunohistochemistry. HAI-1 and HAI-2 showed potential inhibitory effects on cell proliferation, migration and cellular invasion by reduction of matriptase and hepsin expression. This in turn led to an increase in the levels of E-cadherin and Slug, and a reduction in the levels of Vimentin, SIP1, Snail and Twist, and hence ER and PR signal transduction in endometrial cancer cells. The levels of HAI-1 and HAI-2 expression were significantly decreased in endometrial cancer specimens relative to the corresponding normal endometrium specimens. Low HAI-1 and HAI-2 expression was a significant predictor for a poor prognosis compared with high HAI-1 and HAI-2 expression. These findings indicate that HAI-1 and HAI-2 could be considered as therapeutic targets and used as favorable prognosis markers for endometrial cancer.",
keywords = "endometrial cancer, favorable prognosis marker, HAI-1, HAI-2, tumor suppressor gene",
author = "Keiichiro Nakamura and Atsushi Hongo and Junichi Kodama and Yuji Hiramatsu",
year = "2011",
month = "6",
day = "1",
doi = "10.1002/ijc.25606",
language = "English",
volume = "128",
pages = "2613--2624",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "11",

}

TY - JOUR

T1 - The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer

AU - Nakamura, Keiichiro

AU - Hongo, Atsushi

AU - Kodama, Junichi

AU - Hiramatsu, Yuji

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) are Kunitz-type serine protease inhibitors that have a broad inhibitory spectrum against serine proteases. This is the first study to investigate the role of HAI-1 and HAI-2 in endometrial cancer. We investigated the biological functions of HAI-1 and HAI-2 using KLE and HEC-251 endometrial cancer cell lines, thus HAI-1 and HAI-2 were examined in uterine normal endometrium, endometrial hyperplasia and cancer specimens by immunohistochemistry. HAI-1 and HAI-2 showed potential inhibitory effects on cell proliferation, migration and cellular invasion by reduction of matriptase and hepsin expression. This in turn led to an increase in the levels of E-cadherin and Slug, and a reduction in the levels of Vimentin, SIP1, Snail and Twist, and hence ER and PR signal transduction in endometrial cancer cells. The levels of HAI-1 and HAI-2 expression were significantly decreased in endometrial cancer specimens relative to the corresponding normal endometrium specimens. Low HAI-1 and HAI-2 expression was a significant predictor for a poor prognosis compared with high HAI-1 and HAI-2 expression. These findings indicate that HAI-1 and HAI-2 could be considered as therapeutic targets and used as favorable prognosis markers for endometrial cancer.

AB - Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) are Kunitz-type serine protease inhibitors that have a broad inhibitory spectrum against serine proteases. This is the first study to investigate the role of HAI-1 and HAI-2 in endometrial cancer. We investigated the biological functions of HAI-1 and HAI-2 using KLE and HEC-251 endometrial cancer cell lines, thus HAI-1 and HAI-2 were examined in uterine normal endometrium, endometrial hyperplasia and cancer specimens by immunohistochemistry. HAI-1 and HAI-2 showed potential inhibitory effects on cell proliferation, migration and cellular invasion by reduction of matriptase and hepsin expression. This in turn led to an increase in the levels of E-cadherin and Slug, and a reduction in the levels of Vimentin, SIP1, Snail and Twist, and hence ER and PR signal transduction in endometrial cancer cells. The levels of HAI-1 and HAI-2 expression were significantly decreased in endometrial cancer specimens relative to the corresponding normal endometrium specimens. Low HAI-1 and HAI-2 expression was a significant predictor for a poor prognosis compared with high HAI-1 and HAI-2 expression. These findings indicate that HAI-1 and HAI-2 could be considered as therapeutic targets and used as favorable prognosis markers for endometrial cancer.

KW - endometrial cancer

KW - favorable prognosis marker

KW - HAI-1

KW - HAI-2

KW - tumor suppressor gene

UR - http://www.scopus.com/inward/record.url?scp=79953324956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953324956&partnerID=8YFLogxK

U2 - 10.1002/ijc.25606

DO - 10.1002/ijc.25606

M3 - Article

VL - 128

SP - 2613

EP - 2624

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 11

ER -